AzTrials
AzTrials

Nursing EducationNCT07256990

An e-Learning Program for Nurses on Evidence-Based Prevention of CKD

A study testing CKD-prevention e-learning course (Your Kidney... our priority) in people with Nursing Education, run by Shandong University at 1 site in Syria.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Electronic training course to help Syrian nurses prevent chronic kidney disease Why are the investigators doing this study? Chronic kidney disease (CKD) is common in Syria, yet many nurses have not received up-to-date training on early detection or patient education for risk reduction. Read more about this study

Who is it for?
Ages 18 to 60 yearsHealthy volunteers can take part
Conditions the study is for
Nursing Education
What is being tested?
CKD-prevention e-learning course (Your Kidney... our priority)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
30 participants
Where
1 siteSyria
Study dates
21 Jun 2025to 16 Oct 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Registered nurse currently employed in a Syrian hospital
  • Works in nephrology, endocrinology, or cardiology ward
  • Age 18 - 60 years
  • Has smartphone or computer access with internet connection
  • Willing to complete pre- and post-course questionnaires
  • Provides electronic informed consent

Who cannot join

  • Not a registered nurse (e.g., nursing assistant, student)
  • Outside the specified age range
  • Unable to access online materials (no device / no internet)
  • Previous participation in the same e-learning pilot
  • Refuses to give informed consent

Trial locations and contacts

1 site in 1 country.

Syria1 site
  • Tishreen University

    Latakia, 000000

Other trials in Syria

About this study

Official title: Development of Adaptive Intervention for Early Detection and Management of Chronic Kidney Disease in Syria

Electronic training course to help Syrian nurses prevent chronic kidney disease Why are the investigators doing this study? Chronic kidney disease (CKD) is common in Syria, yet many nurses have not received up-to-date training on early detection or patient education for risk reduction. The investigators aim to determine whether a brief, phone-friendly online course can improve nurses' knowledge, day-to-day practice, confidence, and satisfaction.

What will happen? Registered nurses employed in nephrology, cardiology, or endocrinology units will be invited to participate.

Read more

Each nurse will complete a short online quiz and questionnaire before the course.

Participants will then work through seven brief learning modules (videos, posters, case stories, quizzes) on a phone or computer over four weeks.

Two weeks after the final module, participants will repeat the same quiz and questionnaire so the investigators can measure any change.

The investigators will also request feedback on course acceptability and suggestions for improvement.

Possible benefits If the course proves effective, the investigators plan to offer it to additional nurses across Syria and distribute the materials free of charge.

Number of volunteers the investigators plan to enrol 30 nurses (single group; no randomisation). Primary outcome the investigators will measure Change in CKD-prevention knowledge score from baseline to immediately post-course.

Read the detailed description

Study design Prospective, single-arm, pre-test/post-test pilot trial to estimate preliminary effect, feasibility, and acceptability of a seven-module asynchronous e-learning programme on Syrian hospital nurses' CKD-prevention knowledge, self-reported practice, confidence, and satisfaction. No control or randomization will be used.

Setting \& recruitment Thirty registered nurses employed in nephrology, cardiology, or endocrinology wards of Syrian hospitals will be recruited through convenience sampling (hospital WhatsApp groups, professional associations, social-media promotion). Inclusion criteria: (1) registered nurse license, (2) access to smartphone/tablet, (3) willingness to provide electronic informed consent. A dedicated WhatsApp group will be created for announcements and technical support only; no teaching will occur in this group.

Intervention development Content was constructed by the study team and refined through a two-round Delphi panel (two nephrologists, two nutritionists, one senior nurse). Modules map to 2022 KDIGO prevention guidelines and WHO self-care recommendations. All assets (slide-casts ≤ 12 min, branching case vignettes, infographic posters, patient hand-outs) will be bilingual (Arabic/English subtitles) and compressed to ≤ 25 MB to allow offline download.

Delivery logistics Google Classroom will release two modules per week for four weeks. Each module contains: (1) voiced micro-lecture or animation, (2) interactive case study with branched questions, (3) downloadable poster \& patient hand-out, (4) 5-item quiz (pass mark 75 %; unlimited attempts). Engagement analytics (views, quiz attempts, offline downloads) will be extracted from the Google Workspace admin console. Participants will receive a 5 USD mobile-data stipend to mitigate connectivity barriers; no other incentive will be offered.

Data collection timeline Day 0 - Baseline Qualtrics link (demographics, 38-item CKD-knowledge scale, 7-item attitude, 5-item practice, 24-item confidence).

Weeks 1-4 - Intervention delivered. Week 6 - Post-intervention Qualtrics link (same instruments plus 30-item E-Learning Satisfaction Questionnaire and one open-ended feedback item).

No biological samples or patient-level data will be collected. Outcomes Primary: change in CKD-prevention knowledge score (0-38; KR-20 = 0.83). Secondary: change in attitude (7-item, 5-point Likert, CVI = 0.89), self-reported practice (5-item, test-retest r = 0.78), confidence (24-item, Cronbach α = 0.92); module-quiz performance (% correct, attempts to pass); overall satisfaction (0-100; α = 0.93 Arabic version); qualitative feedback (inductive thematic analysis, two independent coders, κ target > 0.80).

Sample size Thirty participants will be enrolled. This number meets pilot-guidance (≥ 30) to detect a large within-group effect (Cohen's d ≥ 0.8) and allows 15 % attrition.

Analysis plan Normality will be examined with Shapiro-Wilk tests. Pre-post differences will be analysed using Wilcoxon signed-rank tests (two-tailed, α = 0.05). Effect size will be reported as r (Z/√N) and Cohen's d with 95 % CIs. Feasibility benchmarks: recruitment ≥ 80 % of target within four weeks, module-completion ≥ 70 %, mean satisfaction ≥ 4/5. Qualitative data will follow Braun \& Clarke six-step thematic analysis.

Ethics \& dissemination Approvals obtained from Shandong University IRB (No. 2023-R-091) and Tishreen University IRB (Ref. N14218). Electronic informed consent will be secured; withdrawal permitted at any time without penalty. Data will be stored on password-protected Qualtrics and OneDrive (256-bit AES). Findings will be submitted to a peer-reviewed journal and presented at nephrology/nursing-education conferences. De-identified dataset and e-learning package will be shared on reasonable request after publication.

Being tested
CKD-prevention e-learning course (Your Kidney... our priority)
Keywords
e-learning, nurses, CKD prevention, Syria, pilot study, pre-post, professional development

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • CKD-prevention e-learning course (Your Kidney... our priority)Behavioural

    'Seven online modules (videos, infographics, case studies, quizzes) delivered via Google Classroom over 4 weeks. Content covers CKD risk-factor screening, lifestyle \& dietary counselling, co-morbidity management, patient education, and program evaluation. Each module includes a short lecture (<12 min), interactive case, downloadable poster, and 5-item quiz (pass ≥75 %). Participants can download materials for offline use.'

Study groups in NCT07256990
Study groupRoleWhat they receive
E-learning groupExperimentalAll eligible nurses receive the 7-module asynchronous e-learning programme on evidence-based CKD prevention.
Receives: Behavioral: CKD-prevention e-learning course (Your Kidney... our priority)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in CKD-prevention knowledge score from baseline to immediately post-intervention

    38-item multiple-choice quiz; score range 0-38; higher score indicates better knowledge.

    Measured: Baseline and Week 6

Secondary outcomes (5)
  1. Change in self-reported practice

    5-item Likert scale (1-5); total score 5-25.

    Measured: Baseline and Week 6

  2. Change in confidence level

    24-item Likert scale (1-5); total score 24-120.

    Measured: Baseline and Week 6

  3. Change in attitude toward CKD prevention

    7-item Likert scale (1-5); total score 7-35.

    Measured: Baseline and Week 6

  4. Overall satisfaction with the e-learning programme

    30-item validated satisfaction scale (0-100 %).

    Measured: Week 6

  5. Module quiz performance

    Percentage of correct answers per 5-item quiz.

    Measured: After each of the 7 modules (Weeks 1-4)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 Dec 2025
  2. Study start21 Jun 2025
  3. Primary completion31 Jul 2025
  4. Study completion16 Oct 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Model description
Single-arm pilot; all eligible nurses receive the same e-learning programme.
Masking
None (open label)
Enrolment
30 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07256990
Sponsor's protocol ID
2023-R-091
Status last verified
Dec 2025
First submitted
19 Nov 2025
Last updated
8 Dec 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: De-identified participant-level data for knowledge, practice, confidence, attitude, and satisfaction scores, together with the study protocol and analytic code, will be made available to researchers who provide a methodologically sound proposal approved by the corresponding author. Data will be shared via a secure, password-protected cloud link for 5 years after publication. Proposals should be directed to fatema92w@gmail.com

Questions about this trial

What is this clinical trial studying?

A study testing CKD-prevention e-learning course (Your Kidney... our priority) in people with Nursing Education, run by Shandong University at 1 site in Syria.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 8 Dec 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Syria. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in CKD-prevention knowledge score from baseline to immediately post-intervention (time frame: Baseline and Week 6). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Dec 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in